<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of
the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 000-23647
LJL BIOSYSTEMS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 77-0360183
------------------------------ ---------------------------
(State or other (I.R.S. Employer
jurisdiction of incorporation) Identification Number)
405 Tasman Drive
Sunnyvale, CA 94089
Telephone: 408 541-8787
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
COMMON STOCK, par value $0.001 per share
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
NONE
--------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ]
Rule 12h-3(b)(1)(i) [ ] Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or
notice date: 1
Pursuant to the requirements of the Securities Exchange Act of 1934, LJL
BioSystems, Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
DATE: August 30, 2000 BY: /s/ JOSEPH D. KEEGAN, Ph.D.
---------------------------------
Joseph D. Keegan, Ph.D.
President
